Medicared For All Logo

Christopher Laganke in Cullman, Alabama

Home Alabama Cullman

Christopher Laganke has Neurology as his primary medical specialty. Their primary office is: 1809 Kress St in Cullman, Alabama.

They're a part of the: North Central Neurology Associates,pc medical group which has around 3 members. You can call their office at 256-739-1210 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Meharry Medical College School Of Medicine and graduated in 1990 (around 34 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Christopher Cole Laganke Office Phone and Directions

Christopher Laganke
North Central Neurology Associates,pc
1809 Kress St
Cullman, Alabama 35058
256-739-1210


Patient Ratings
Please rate your experience with Christopher Laganke below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 256-739-1210


Enter a starting address:


Healthcare Info for Christopher Laganke

Medical School: Meharry Medical College School Of Medicine
Graduation Year: 1990
The Primary Medical Specialty for Christopher Laganke is listed as: Neurology
Approximate Years of Experience: 34
PAC (PECOS ID)#: 9739120528
NPI #: 1811931546
NPI Created On: 06/15/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 2084N0400X
License Number:
16117
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Injection of chemical for destruction of facial and neck nerve muscles on both sides of face
  2. Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin
  3. Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles
  4. Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles
  5. Urinalysis, manual test
  6. Needle measurement and recording of electrical activity of muscles of arm or leg limited study
  7. Nerve transmission studies, 7-8 studies
  8. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  9. Infusion into a vein for therapy, prevention, or diagnosis
  10. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  11. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  12. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  13. Infusion of chemotherapy into a vein up to 1 hour
  14. Infusion of chemotherapy into a vein
  15. New patient office or other outpatient visit, typically 45 minutes
  16. New patient office or other outpatient visit, typically 60 minutes
  17. Established patient office or other outpatient visit, typically 15 minutes
  18. Established patient office or other outpatient, visit typically 25 minutes
  19. Injection, alemtuzumab, 1 mg
  20. Injection, onabotulinumtoxina, 1 unit

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788710381

Being Disputed:: No

Product Related: Yes


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710383

Being Disputed:: No

Product Related: Yes


Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710385

Being Disputed:: No

Product Related: Yes


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710387

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: Ponvory

Open Associated Drug #1: 50458-707-14


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710395

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: Ponvory

Open Associated Drug #1: 50458-707-14


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710389

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: Ponvory

Open Associated Drug #1: 50458-707-14


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710391

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: Ponvory

Open Associated Drug #1: 50458-707-14


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788710393

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: Ponvory

Open Associated Drug #1: 50458-707-14


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792554829

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PARKINSONS DISEASE

Name of Drug #1: INBRIJA

Open Associated Drug #1: 10144-342-32


Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792554827

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PARKINSONS DISEASE

Name of Drug #1: INBRIJA

Open Associated Drug #1: 10144-342-32


Neurology Professionals in Cullman

1890 Al Hwy 157
Cullman, AL
Crmc Medical Group Llc

1890 Al Hwy 157
Cullman, AL
Crmc Medical Group Llc

Providers in North Central Neurology Associates,pc

1.Cynthia Kimbrough

1809 Kress St
Cullman Al 35058-0001
North Central Neurology Associates,pc
Nurse Practitioner

2.Christopher Laganke

1809 Kress St
Cullman Al 35058-0001
North Central Neurology Associates,pc
Neurology

3.Ryan Shannon

1809 Kress St
Cullman Al 35058-0001
North Central Neurology Associates,pc
Nurse Practitioner

View all 3 members of North Central Neurology Associates,pc medical group